ArticleNature communications2022

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance.

Mariela Cortés-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.